Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  Irritable Bowel Syndrome

  Free Subscription


Articles published in J Gastroenterol

Retrieve available abstracts of 15 articles:
HTML format
Text format



Single Articles


    January 2018
  1. ONO M, Kato M, Miyamoto S, Tsuda M, et al
    Multicenter observational study on functional bowel disorders diagnosed using Rome III diagnostic criteria in Japan.
    J Gastroenterol. 2018 Jan 5. pii: 10.1007/s00535-017-1428.
    PubMed     Text format     Abstract available


    August 2017
  2. NAKAJIMA A, Seki M, Taniguchi S
    Determining an optimal clinical dose of elobixibat, a novel inhibitor of the ileal bile acid transporter, in Japanese patients with chronic constipation: a phase II, multicenter, double-blind, placebo-controlled randomized clinical trial.
    J Gastroenterol. 2017 Aug 24. doi: 10.1007/s00535-017-1383.
    PubMed     Text format     Abstract available


  3. SU T, Lai S, Lee A, He X, et al
    Meta-analysis: proton pump inhibitors moderately increase the risk of small intestinal bacterial overgrowth.
    J Gastroenterol. 2017 Aug 2. doi: 10.1007/s00535-017-1371.
    PubMed     Text format     Abstract available


    May 2016
  4. HAN K, Wang J, Seo JG, Kim H, et al
    Efficacy of double-coated probiotics for irritable bowel syndrome: a randomized double-blind controlled trial.
    J Gastroenterol. 2016.
    PubMed     Text format     Abstract available


    April 2016
  5. YAMADA E, Tsunoda S, Abe T, Uchida E, et al
    Factors associated with poor therapeutic response in outpatients with irritable bowel syndrome: a multicenter study in Japan.
    J Gastroenterol. 2016.
    PubMed     Text format     Abstract available


  6. NOZU T, Miyagishi S, Nozu R, Takakusaki K, et al
    Lipopolysaccharide induces visceral hypersensitivity: role of interleukin-1, interleukin-6, and peripheral corticotropin-releasing factor in rats.
    J Gastroenterol. 2016.
    PubMed     Text format     Abstract available


  7. OSHIMA T, Miwa H
    Gastrointestinal mucosal barrier function and diseases.
    J Gastroenterol. 2016.
    PubMed     Text format     Abstract available


    January 2016
  8. FUKUDO S, Kinoshita Y, Okumura T, Ida M, et al
    Effect of ramosetron in female patients with irritable bowel syndrome with diarrhea: a phase III long-term study.
    J Gastroenterol. 2016.
    PubMed     Text format     Abstract available


    June 2015
  9. FUKUDO S, Kaneko H, Akiho H, Inamori M, et al
    Evaluation of Kampo medicine in the clinical practice guideline for irritable bowel syndrome.
    J Gastroenterol. 2015.
    PubMed     Text format    


    May 2015
  10. NOZU T, Okumura T
    Corticotropin-releasing factor receptor type 1 and type 2 interaction in irritable bowel syndrome.
    J Gastroenterol. 2015.
    PubMed     Text format     Abstract available


    April 2015
  11. TALLEY NJ, Holtmann G, Walker MM
    Therapeutic strategies for functional dyspepsia and irritable bowel syndrome based on pathophysiology.
    J Gastroenterol. 2015.
    PubMed     Text format     Abstract available


  12. MOTOO Y
    Description of Kampo medicines in the clinical practice guidelines for irritable bowel syndrome.
    J Gastroenterol. 2015.
    PubMed     Text format    


    December 2014
  13. FUKUDO S, Kaneko H, Akiho H, Inamori M, et al
    Evidence-based clinical practice guidelines for irritable bowel syndrome.
    J Gastroenterol. 2014.
    PubMed     Text format     Abstract available


    November 2014
  14. OSHIMA T, Fukui H, Watari J, Miwa H, et al
    Childhood abuse history is associated with the development of dyspepsia: a population-based survey in Japan.
    J Gastroenterol. 2014.
    PubMed     Text format     Abstract available


    May 2014
  15. VANUYTSEL T, Tack JF, Boeckxstaens GE
    Treatment of abdominal pain in irritable bowel syndrome.
    J Gastroenterol. 2014.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Irritable Bowel Syndrome is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: